Trial site
Northwest Cancer Specialists, P.C.
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Colorectal cancer3 trials
- Gastric and oesophageal cancer3 trials
- Cervical cancer2 trials
- Endometrial cancer2 trials
- Bladder cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 1/23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting4 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Pfizer5 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Bristol-Myers Squibb2 trials
- Agenus Inc.1 trial
- Faeth Therapeutics1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer2 recruiting
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Terminated
Completed
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026